3′,5′-Cyclic adenosine 5′-monophosphate response element-dependent transcriptional regulation of the secretogranin II gene promoter depends on gonadotropin-releasing hormone-induced mitogen-activated protein kinase activation and the transactivator activating transcription factor 3

Endocrinology

Volumn 149, Issue 2, 2008, Pages 783-792

  Xie, Jianjun ^a   Roberson, Mark S ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CYCLIC AMP; GONADORELIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; SECRETOGRANIN II; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; ATF3 PROTEIN, RAT; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; SECRETOGRANIN 2, RAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CATALYSIS; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; DNA BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE CONTROL; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; CELL LINE; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; PROMOTER REGION; RAT; TRANSACTIVATION;

ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; CELL LINE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE DELETION; GENE EXPRESSION REGULATION; GONADOTROPIN-RELEASING HORMONE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS (GENETICS); RATS; RNA, SMALL INTERFERING; SECRETOGRANIN II; TRANS-ACTIVATION (GENETICS);

EID: 38549109707     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0694     Document Type: Article

References (63)

1. Taupenot L, Harper KL, O'Connor DT 2003 The chromogranin- secretogranin family. N Engl J Med 348:1134-1149
2. Chanat E, Hubert JF, De MM, Guiraud JM, Duval J 1986 Effect of LHRH on the synthesis and phosphorylation of proteins in gonadotropic cells. Ann Endocrinol (Paris) 47:45-47
3. Chanat E, Hubert JF, Sion B, De MM, Duval J 1986 LHRH promotes the synthesis and release of a 87,000 Da protein (GP-87) by enriched gonadotrophs. Mol Cell Endocrinol 46:109-119
4. Chanat E, Duval J 1987 LHRH-stimulated release of stored and newly synthesized gonadotrope polypeptide (GP-87) by cultured rat gonadotrophs. Neuropeptides 9:177-183
5. Chanat E, Cozzi MG, Sion B, De MM, Zanini A, Duval J 1988 The gonadotrope polypeptide (GP 87) released from pituitary cells under luteinizing hormone-releasing hormone stimulation is a secretogranin II form. Biochimie (Paris) 70:1361-1368
6. Sion B, Chanat E, Duval J, Thieulant ML 1988 Peptides co-released with luteinizing hormone by perifused pituitary cell aggregates. Mol Cell Endocrinol 60:151-161
7. Conn PM, Janovick JA, Braden TD, Maurer RA, Jennes L 1992 SIIp: a unique secretogranin/chromogranin of the pituitary released in response to gonadotropin-releasing hormone. Endocrinology [Erratum (1992) 131:1866] 130:3033-3040
8. Nicol L, McNeilly JR, Stridsberg M, McNeilly AS 2004 Differential secretion of gonadotrophins: investigation of the role of secretogranin II and chromogranin A in the release of LH and FSH in LβT2 cells. J Mol Endocrinol 32:467-480
9. Nicol L, McNeilly JR, Stridsberg M, Crawford JL, McNeilly AS 2002 Influence of steroids and GnRH on biosynthesis and secretion of secretogranin II and chromogranin A in relation to LH release in LβT2 gonadotroph cells. J Endocrinol 174:473-483
10. Crawford JL, McNeilly AS 2002 Co-localisation of gonadotrophins and granins in gonadotrophs at different stages of the oestrous cycle in sheep. J Endocrinol 174:179-194
11. Crawford JL, McNeilly JR, Nicol L, McNeilly AS 2002 Promotion of intragranular co-aggregation with LH by enhancement of secretogranin II storage resulted in increased intracellular granule storage in gonadotrophs of GnRH-deprived male mice. Reproduction 124:267-277
12. Kakar SS, Wei N, Mulchahey JJ, LeBoeuf RD, Neill JD 1993 Regulation of expression of secretogranin II mRNA in female rat pituitary and hypothalamus. Neuroendocrinology 57:422-431
13. Kitahara K, Sakai Y, Hosaka M, Hira Y, Kakizaki H, Watanabe T 2007 Effects of a depot formulation of the GnRH agonist leuprorelin on the ultrastructure of male rat pituitary gonadotropes. Arch Histol Cytol 70:79-93
14. Anouar Y, Duval J 1991 Differential expression of secretogranin II and chromogranin A genes in the female rat pituitary through sexual maturation and estrous cycle. Endocrinology 128:1374-1380
15. Anouar Y, Benie T, De MM, Counis R, Duval J 1991 Estradiol negatively regulates secretogranin II and chromogranin A messenger ribonucleic acid levels in the female rat pituitary but not in the adrenal. Endocrinology 129:2393-2399
16. Anouar Y, Duval J 1992 Direct estradiol down-regulation of secretogranin II and chromogranin A mRNA levels in rat pituitary cells. Mol Cell Endocrinol 88:97-104
17. Thompson ME, Valentine DL, Strada SJ, Wagner JA, Scammell JG 1994 Transcriptional regulation of secretogranin II and chromogranin B by cyclic AMP in a rat pheochromocytoma cell line. Mol Pharmacol 46:880-889
18. Jones LC, Day RN, Pittler SJ, Valentine DL, Scammell JG 1996 Cell-specific expression of the rat secretogranin II promoter. Endocrinology 137:3815-3822
19. Jones LC, Scammell JG 1998 The cAMP-response element mediates induction of secretogranin II by CHX and FSK in GH4C1 cells. Am J Physiol 274:E656-E664
20. Desmoucelles C, Vaudry H, Eiden LE, Anouar Y 1999 Synergistic action of upstream elements and a promoter-proximal CRE is required for neuroendocrine cell-specific expression and second-messenger regulation of the gene encoding the human secretory protein secretogranin II. Mol Cell Endocrinol 157:55-66
21. Scammell JG, Reddy S, Valentine DL, Coker TN, Nikolopoulos SN, Ross RA 2000 Isolation and characterization of the human secretogranin II gene promoter. Brain Res Mol Brain Res 75:8-15
22. Song SB, Rhee M, Roberson MS, Maurer RA, Kim KE 2003 Gonadotropin-releasing hormone-induced stimulation of the rat secretogranin II promoter involves activation of CREB. Mol Cell Endocrinol 199:29-36
23. Roberson MS, Misra-Press A, Laurance ME, Stork PJ, Maurer RA 1995 A role for mitogen-activated protein kinase in mediating activation of the glycoprotein hormone α-subunit promoter by gonadotropin-releasing hormone. Mol Cell Biol 15:3531-3539
24. Sundaresan S, Colin IM, Pestell RG, Jameson JL 1996 Stimulation of mitogen-activated protein kinase by gonadotropin-releasing hormone: evidence for the involvement of protein kinase C. Endocrinology 137:304-311
25. Levi NL, Hanoch T, Benard O, Rozenblat M, Harris D, Reiss N, Naor Z, Seger R 1998 Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary αT3-1 cell line is mediated by protein kinase C, c-Src, and CDC42. Mol Endocrinol 12:815-824
26. Roberson MS, Zhang T, Li HL, Mulvaney JM 1999 Activation of the p38 mitogen-activated protein kinase pathway by gonadotropin-releasing hormone. Endocrinology 140:1310-1318
27. Mulvaney JM, Zhang T, Fewtrell C, Roberson MS 1999 Calcium influx through L-type channels is required for selective activation of extracellular signal-regulated kinase by gonadotropin-releasing hormone. J Biol Chem 274:29796-29804
28. Mulvaney JM, Roberson MS 2000 Divergent signaling pathways requiring discrete calcium signals mediate concurrent activation of two mitogen-activated protein kinases by gonadotropin-releasing hormone. J Biol Chem 275:14182-14189
29. Pearson G, Robinson F, Beers GT, Xu BE, Karandikar M, Berman K, Cobb MH 2001 Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153-183
30. Raman M, Cobb MH 2003 MAP kinase modules: many roads home. Curr Biol 13:R886-R888
31. Ruf F, Fink MY, Sealfon SC 2003 Structure of the GnRH receptor-stimulated signaling network: insights from genomics. Front Neuroendocrinol 24:181-199
32. Holland MP, Bliss SP, Berghorn KA, Roberson MS 2004 A role for CCAAT/ enhancer-binding protein β in the basal regulation of the distal-less 3 gene promoter in placental cells. Endocrinology 145:1096-1105
33. Xie J, Bliss SP, Nett TM, Ebersole BJ, Sealfon SC, Roberson MS 2005 Transcript profiling of immediate early genes reveals a unique role for activating transcription factor 3 in mediating activation of the glycoprotein hormone α-subunit promoter by gonadotropin-releasing hormone. Mol Endocrinol 19:2624-2638
34. Roberson MS, Ban M, Zhang T, Mulvaney JM 2000 Role of the cyclic AMP response element binding complex and activation of mitogen-activated protein kinases in synergistic activation of the glycoprotein hormone α subunit gene by epidermal growth factor and forskolin. Mol Cell Biol 20:3331-3344
35. Windle JJ, Weiner RI, Mellon PL 1990 Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice. Mol Endocrinol 4:597-603
36. Horn F, Bilezikjian LM, Perrin MH, Bosma MM, Windle JJ, Huber KS, Blount AL, Hille B, Vale W, Mellon PL 1991 Intracellular responses to gonadotropin-releasing hormone in a clonal cell line of the gonadotrope lineage. Mol Endocrinol 5:347-355
37. English JM, Cobb MH 2002 Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci 23:40-45
38. Dickens M, Rogers JS, Cavanagh J, Raitano A, Xia Z, Halpern JR, Greenberg ME, Sawyers CL, Davis RJ 1997 A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277:693-696
39. Yasuda J, Whitmarsh AJ, Cavanagh J, Sharma M, Davis RJ 1999 The JIP group of mitogen-activated protein kinase scaffold proteins. Mol Cell Biol 19:7245-7254
40. Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B, Wright A, Vanderbilt C, Cobb MH 2001 MAP kinases. Chem Rev 101:2449-2476
41. Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Davis RJ, Johnson GL, Karin M 1994 Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266:1719-1723
42. Flory E, Weber CK, Chen P, Hoffmeyer A, Jassoy C, Rapp UR 1998 Plasma membrane-targeted Raf kinase activates NF-κB and human immunodeficiency virus type 1 replication in T lymphocytes. J Virol 72:2788-2794
43. Mineo C, Anderson RG, White MA 1997 Physical association with ras enhances activation of membrane-bound raf (RafCAAX). J Biol Chem 272:10345-10348
44. Blumer KJ, Johnson GL, Lange-Carter CA 1994 Mammalian mitogen-activated protein kinase kinase kinase (MEKK) can function in a yeast mitogen-activated protein kinase pathway downstream of protein kinase C. Proc Natl Acad Sci USA 91:4925-4929
45. Fischer-Colbrie R, Kirchmair R, Kahler CM, Wiedermann CJ, Saria A 2005 Secretoneurin: a new player in angiogenesis and chemotaxis linking nerves, blood vessels and the immune system. Curr Protein Pept Sci 6:373-385
46. Mahata SK, Mahata M, Livsey CV, Gerdes HH, Huttner WB, O'Conner DT 1999 Neuroendocrine cell type-specific and inducible expression of the secretogranin II gene: crucial role of cyclic adenosine monophosphate and serum response elements. Endocrinology 140:739-749
47. Wurmbach E, Yuen T, Ebersole BJ, Sealfon SC 2001 Gonadotropin-releasing hormone receptor-coupled gene network organization. J Biol Chem 276:47195-47201
48. Zhang T, Wolfe MW, Roberson MS 2001 An early growth response protein (Egr) 1 cis-element is required for gonadotropin-releasing hormone-induced mitogen-activated protein kinase phosphatase 2 gene expression. J Biol Chem 276:45604-45613
49. Zhang T, Roberson MS 2006 Role of MAP kinase phosphatases in GnRH-dependent activation of MAP kinases. J Mol Endocrinol 36:41-50
50. Duan WR, Ito M, Park Y, Maizels ET, Hunzicker-Dunn M, Jameson JL 2002 GnRH regulates early growth response protein 1 transcription through multiple promoter elements. Mol Endocrinol 16:221-233
51. Lee SL, Sadovsky Y, Swirnoff AH, Polish JA, Goda P, Gavrilina G, Milbrandt J 1996 Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1). Science 273:1219-1221
52. Topilko P, Schneider-Maunoury S, Levi G, Trembleau A, Gourdji D, Driancourt MA, Rao CV, Charnay P 1998 Multiple pituitary and ovarian defects in Krox-24 (NGFI-A, Egr-1)-targeted mice. Mol Endocrinol 12:107-122
53. Zhang T, Mulvaney JM, Roberson MS 2001 Activation of mitogen-activated protein kinase phosphatase 2 by gonadotropin-releasing hormone. Mol Cell Endocrinol 172:79-89
54. Bonfil D, Chuderland D, Kraus S, Shahbazian D, Friedberg I, Seger R, Naor Z 2004 Extracellular signal-regulated kinase, Jun N-terminal kinase, p38, and c-Src are involved in gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone follicle-stimulating hormone β-subunit promoter. Endocrinology 145:2228-2244
55. Ellsworth BS, White BR, Burns AT, Cherrington BD, Otis AM, Clay CM 2003 c-Jun N-terminal kinase activation of activator protein-1 underlies homologous regulation of the gonadotropin-releasing hormone receptor gene in αT3-1 cells. Endocrinology 144:839-849
56. Ellsworth BS, Burns AT, Escudero KW, Duval DL, Nelson SE, Clay CM 2003 The gonadotropin releasing hormone (GnRH) receptor activating sequence (GRAS) is a composite regulatory element that interacts with multiple classes of transcription factors including Smads, AP-1 and a forkhead DNA binding protein. Mol Cell Endocrinol 206:93-111
57. Hai T, Wolfgang CD, Marsee DK, Allen AE, Sivaprasad U 1999 ATF3 and stress responses. Gene Expr 7:321-335
58. Nawa T, Nawa MT, Adachi MT, Uchimura I, Shimokawa R, Fujisawa K, Tanaka A, Numano F, Kitajima S 2002 Expression of transcriptional repressor ATF3/LRF1 in human atherosclerosis: colocalization and possible involvement in cell death of vascular endothelial cells. Atherosclerosis 161:281-291
59. Yan C, Wang H, Boyd DD 2002 ATF3 represses 72-kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent trans-activation of the collagenase promoter. J Biol Chem 277:10804-10812
60. Zhang C, Kawauchi J, Adachi MT, Hashimoto Y, Oshiro S, Aso T, Kitajima S 2001 Activation of JNK and transcriptional repressor ATF3/LRF1 through the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine. Biochem Biophys Res Commun 289:718-724
61. Mashima T, Udagawa S, Tsuruo T 2001 Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis. J Cell Physiol 188:352-358
62. Wang J, Cao Y, Steiner DF 2003 Regulation of proglucagon transcription by activated transcription factor (ATF) 3 and a novel isoform, ATF3b, through the cAMP-response element/ATF site of the proglucagon gene promoter. J Biol Chem 278:32899-32904
63. James CG, Woods A, Underhill TM, Beier F 2006 The transcription factor ATF3 is up-regulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription. BMC Mol Biol 7:30